SIRT1 and neoplasm: In this study, we found that MA, a pentacyclic triterpenoid, not only attenuated DOX-induced cardiotoxic effects through the SIRT1-activated signaling pathway but also enhanced the anticancer effects of DOX, providing a dual beneficial effect on tumor therapy.